Hou et al. found YTHDF2 expression level is associated with clinical outcome and YTHDF2 deletion promotes hepatocellular carcinoma (HCC) growth, tumor angiogenesis and distant metastasis [52]. This evidence concerns the gene YTHDF2 and hepatocellular carcinoma.